Page-2 of GAVI

Pneumosil: India’s First Pneumonia Vaccine

The Serum Institute of India recently unveiled the first indigenously developed Pneumococcal Vaccine called Pneumosil. The vaccine was launched by the Union Health Minister Harsh Vardhan. About the Vaccine Pneumosil was developed through collaboration with Bill and Melinda Gates Foundation ..

Month: 

UNICEF’s COVID-19 Vaccine Market Dashboard

The UNICEF has recently launched the COVID-19 Vaccine Market Dashboard as the designated COVAX procurement coordinator and procurement agent. About the Dashboard It is an interactive tool for countries and industries to follow the developments of the rapidly evolving COVID-19 ..

Month: 

India’s First Indigenous Vaccine against Pneumonia

The first Indian vaccine against Pneumonia has been developed by Serum Institute of India. The vaccine is to be made available to the domestic makers soon. Highlights India has access to pneumonia vaccines. However, the new locally developed vaccine is ..

Month: 

Mission COVID Suraksha: Key Facts

On November 12, 2020, the Finance Minister Nirmala Sitharaman announced Mission COVID Suraksha. Under the mission, the Government of India has allocated Rs 900 crores to the research and development of COVID-19 vaccines in India. The funds allocated do not ..

Month: 

India-Bangladesh sign MoU on COVID-19 Vaccine

On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights ..

Month: 

COVID-19 Vaccine: Serum Institute of India to produce additional 100 million doses for India

The Serum Institute of India recently announced that it will produce additional 100 million COVID-19 vaccines for low- and middle- income countries by 2021. Highlights Earlier, the institute had committed to deliver 100 million vaccines. Now a total of 200 ..

Month: